1. Home
  2. UCL vs ADVB Comparison

UCL vs ADVB Comparison

Compare UCL & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo uCloudlink Group Inc.

UCL

uCloudlink Group Inc.

BUY

Current Price

$0.24

Market Cap

10.6M

ML Signal

BUY

ADVB

Advanced Biomed Inc.

HOLD

Current Price

$3.98

Market Cap

8.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UCL
ADVB
Founded
2014
2014
Country
Hong Kong
Hong Kong
Employees
N/A
N/A
Industry
Telecommunications Equipment
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.6M
8.6M
IPO Year
2019
2023

Fundamental Metrics

Financial Performance
Metric
UCL
ADVB
Price
$0.24
$3.98
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 372.5K
15.3K
Earning Date
11-11-2026
10-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 3431.25
EPS
N/A
★ 5.33
Revenue
N/A
★ $127,637.00
Revenue This Year
N/A
N/A
Revenue Next Year
$15.99
N/A
P/E Ratio
$13.72
★ $0.92
Revenue Growth
N/A
N/A
52 Week Low
$0.22
$3.66
52 Week High
$2.63
$113.80

Technical Indicators

Market Signals
Indicator
UCL
ADVB
Relative Strength Index (RSI) 25.84 23.26
Support Level N/A $3.86
Resistance Level $0.44 $5.59
Average True Range (ATR) 0.02 0.48
MACD 0.00 -0.15
Stochastic Oscillator 10.37 8.94

Price Performance

Historical Comparison
UCL
ADVB

About UCL uCloudlink Group Inc.

Ucloudlink Group Inc is engaged in the provision of data connectivity services and sales of Wi-Fi terminals and data-related products globally. Its uCloudlink cloud SIM platform is designed for shared mobile data connectivity services by allocating the SIM cards remotely and dynamically to users. Ucloudlink's core business is to provide mobile data connectivity services at competitive prices, which it delivers through a range of hardware products and service solutions to its business partners, retail, and enterprise customers. The main hardware terminals offered by the company include portable Wi-Fi terminals, smartphones, and smart-hardware products for international and local mobile data connectivity services. Geographically, it generates maximum revenue from Japan.

About ADVB Advanced Biomed Inc.

Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.

Share on Social Networks: